Regulus Therapeutics Inc.

(RGLS) Trade

By |

Profile

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes.

Contact Information

Website: www.regulusrx.com
Email: information@regulusrx.com
Main Phone: +1 858 202-6300
Address: 10628 Science Center Drive
Address 2: Suite 225
State: CA
City / Town: San Diego
Country: US
Postal Code: 92121

Issuer Information

Exchange: NSC
CEO: Joseph P. Hagan
Employees: 24
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes.

Contact Information

Website: www.regulusrx.com
Email: information@regulusrx.com
Main Phone: +1 858 202-6300
Address: 10628 Science Center Drive
Address 2: Suite 225
State: CA
City / Town: San Diego
Country: US
Postal Code: 92121

Issuer Information

Exchange: NSC
CEO: Joseph P. Hagan
Employees: 24
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.47 $ -0.0058 (-1.22%)
Last Price 0.47 Change $ -0.0058 Change % -1.22 Tick N/A
Bid 0.47 Bid Size 200.00 Ask 0.47 Ask Size 400.00
Open 0.48 High 0.50 Low 0.47 Prev Close 0.48
Last Trade Volume 161,105 52 Wk Hi 1.74 52 Wk Low 0.43
Market Cap 16.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 35,922,916.00 EPS (TTM) -0.96 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 10
Number of Buys 1 10
Number of Sells 0 0
Net Activity 7695 2130745
Last 10 Buys Shares
Timothy Michael Wright 1,000
William H. Rastetter 1,000
Joseph P. Hagan 1,000
Stelios Papadopoulos 1,000
Daniel R. Chevallard 1,000
Stelios Papadopoulos 1,000
Stelios Papadopoulos 1,000
William H. Rastetter 1,000
Joseph P. Hagan 1,000
Mark G. Foletta 1,000
Last 10 Sell Shares
Kleanthis G. Xanthopoulos 1,000
Kleanthis G. Xanthopoulos 1,000
Kleanthis G. Xanthopoulos 1,000
Bruce L.A. Carter 1,000
Kleanthis G. Xanthopoulos 1,000
Kleanthis G. Xanthopoulos 1,000
Kleanthis G. Xanthopoulos 1,000
Kleanthis G. Xanthopoulos 1,000
Kleanthis G. Xanthopoulos 1,000
Kleanthis G. Xanthopoulos 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 1 1 1 1
Mean Target Price Estimate 1.77 1.77 1.77 1.77
Standard Deviation 0.77 0.77 0.77 0.77
Date of Most Recent Estimate 05/11/18 05/11/18 05/11/18 05/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 4 4 4 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.33 2.33 2.33 2.2